Head-to-head · WeighScore
Belle Health vs Pepti
The verdict
Pepti takes it — 78.8/100 to 73.8/100.
Pepti grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pepti prices both molecules all-in with no membership fee, names its medical director, and still carries an FDA-cleared badge on a homepage whose product pages say the opposite.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Belle Health | Pepti |
|---|---|---|
| WeighScore | 73.8/100 | 78.8/100 |
| Grade | C | C+ |
| Scorecard rank | #75 | #44 |
| Semaglutide | From $109/mo (compounded; supply terms unverified) | $109 per 28 days (all-in; billing can fall twice in one calendar month) |
| Tirzepatide | From $179/mo (compounded; supply terms unverified) | $179 per 28 days (all-in; billing can fall twice in one calendar month) |
| Coverage | All 50 states | All 50 states plus Washington, D.C. |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #75 · C
FDAWarning letter issued to Belle Health LLC dba Belle in February 2026. See the FDA warning-letter database.
Strengths
- Weekly live group sessions with a named registered dietitian are included
- Provider review, nurse support, injection supplies and shipping are included
- Advertises the same price across dose levels
- Terms state telehealth availability in all 50 states
Where it loses points
- Starting prices do not establish the required supply length, upfront charge or renewal amount
- Compounded medications are not FDA-approved finished products
- Prescription products are nonrefundable after shipment; subscriptions may renew automatically
- FDA issued Belle Health LLC dba Belle a warning letter in February 2026; the letter is public in FDA's warning-letter database
Graded #44 · C+
Strengths
- The figure is stated as the full price with no membership fee, free shipping included, on the product page itself
- Names a medical director by name and board certification, and a second named provider
- Baseline labs are described as included when a clinician requires them, with deeper panels priced openly at $149 and a $129 monthly bloodwork plan
- Coverage is all 50 states and the District of Columbia, stated without a hedge
- Roughly forty prescription peptide products are priced alongside the GLP-1 lines
Where it loses points
- The site prints $79 on its own semaglutide cost page and $109 on the same page, and $149 against $179 for tirzepatide; the figures that transact are $109 and $179
- The product pages label the figure an all-in monthly price while the billing terms set the cycle at 28 days and warn it can bill twice in one calendar month
- An “FDA cleared” badge sits in the homepage trust cluster while the product pages state that compounded medication is neither FDA-approved nor FDA-cleared
- “Our pharmacy partners” names exactly one, Olympia, with no legal entity or address, while the same page says the filling pharmacy varies by patient
- Payment is taken before a physician reviews the intake, and the refund is the remedy
- Labs are conditional rather than included, despite plan copy that reads as though they are standard
Also worth a look
Another provider to compare: CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.